Drug Information

Drug General Information
Drug ID
D0R7HA
Former ID
DIB007176
Drug Name
DPP-IV inhibitors
Synonyms
DPP-IV inhibitors (type 2 diabetes); DPP-IV inhibitors (type 2 diabetes), Biovitrum; DPP-IV inhibitors (type 2 diabetes), Santhera; Dipeptidyl-peptidase IV inhibitors (type 2 diabetes), Santhera
Indication Non-insulin dependent diabetes [ICD10:E11.9] Investigative [552161]
Company
Graffinity Pharmaceuticals AG
Canonical SMILES
C1CC[C@H](N1C(=O)C[C@@H](Cc1cccc(c1)Cl)N)CNC(=O)c1cc(cc<br />c1)S(=O)(=O)C
Target and Pathway
Target(s) Dipeptidyl peptidase IV Target Info Inhibitor [543447]
KEGG Pathway Protein digestion and absorption
NetPath Pathway IL2 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
References
Ref 552161WO patent application no. 03000181, DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OF DIABETES.
Ref 543447(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1612).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.